ci 966 has been researched along with hinokinin in 1 studies
Studies (ci 966) | Trials (ci 966) | Recent Studies (post-2010) (ci 966) | Studies (hinokinin) | Trials (hinokinin) | Recent Studies (post-2010) (hinokinin) |
---|---|---|---|---|---|
14 | 0 | 4 | 44 | 0 | 22 |
Protein | Taxonomy | ci 966 (IC50) | hinokinin (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.76 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 8.35 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade e Silva, ML; Cunha, WR; Fontana, AC; Magalhães, LG; Mortensen, OV; Pereira, AC; Souza Rezende, KC; Timple, JM | 1 |
1 other study(ies) available for ci 966 and hinokinin
Article | Year |
---|---|
The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.
Topics: 4-Butyrolactone; Attention Deficit Disorder with Hyperactivity; Benzodioxoles; Dioxoles; Dopamine; Dose-Response Relationship, Drug; GABA Plasma Membrane Transport Proteins; Humans; Lignans; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism | 2013 |